ISOQUINOLINE DERIVATIVES

摘要

New compounds of the general formula (I) are strong and selective inhibitors of PDE4 enzyme and they are presumably suitable for the treatment of for instance asthma, chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis.